CUR - Neuralstem Stock Trading
News, Short Squeeze, Breakout and More Instantly...
-
GERMANTOWN, Md. , Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today provided the following letter from Dr. Ken Carter , the Company's Executive Chairm...
-
GERMANTOWN, Md. , May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq:SNCA), a clinical-stage biopharmaceutical company developing novel treatments for various diseases of high unmet medical need, today announced the closing of its previously announced $5 million registered...
-
GERMANTOWN, Md. , Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, will begin trading on the Nasdaq Capital Market under the ticker symbol, NASDAQ: SNCA begi...
Important Investor News Alert (OTCMKTS: BNOW)
-
SACRAMENTO, CA, Jan. 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BOON Industries (OTC PINK:BNOW) (“BOON” or the “Company”), announces the Chairman Letter. Justin Gonzalez, Chairman and CEO, stated “The Company has completed its testing and complia...